Drugs / CDC infusion
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03129568 | Apr 2017 → Sep 2018 | dilated cardiomyopathy | Okayama University | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CDC infusion | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03129568 ↗ |
| Known as | CDCs | “Although cardiosphere-derived cells (CDCs) improve cardiac function and outcomes in patients with single ventricle physiology, little is known about their safety and...” PMID 33298561 ↗ Dec 2020 |
| Modality | Cell therapy | “Although cardiosphere-derived cells (CDCs) improve cardiac function and outcomes in patients with single ventricle physiology” PMID 33298561 ↗ Dec 2020 |
| Route | Other | “Collectively, intracoronary CDC administration is safe and improves cardiac function through CDCex in a porcine model of DCM.” PMID 33298561 ↗ Dec 2020 |